Department of Health and Human Services June 19, 2014 – Federal Register Recent Federal Regulation Documents
Results 1 - 14 of 14
Agency Information Collection Activities: Submission for OMB Review; Comment Request; OAA Title III-E Evaluation
The Administration for Community Living (formerly the Administration on Aging (AoA)) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Draft Guidance for Industry on Uncomplicated Gonorrhea: Developing Drugs for Treatment; Availability
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled ``Uncomplicated Gonorrhea: Developing Drugs for Treatment.'' The purpose of this draft guidance is to assist sponsors in the development of new antibacterial drugs for the treatment of uncomplicated gonorrhea.
Request for Information: The National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods Requests Data and Information on Devices and/or Technologies Used for Identifying Potential Inhalation Hazards
The National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) requests available data and information on devices and/or technologies currently used for identifying potential inhalation hazards. Submitted information will be used to assess the state of the science and determine the technical needs for a dynamic nonanimal system to assess the potential toxicity of inhaled chemicals and nanomaterials.
Symposium on Assessing Exposures and Health Effects Related to Indoor Biomass Fuel Burning; Notice of Meeting and Registration Information
The National Toxicology Program (NTP) announces a symposium on ``Assessing Exposures and Health Effects Related to Indoor Biomass Fuel Burning.'' The symposium will bring together researchers working in the area of indoor biomass fuel burning emissions and health effects to discuss the latest science, policy, and future directions. The meeting is open to the public. Registration is requested for attendance and required to access the webcast. Information about the meeting and registration are available at https://ntp.niehs.nih.gov/go/41613.
Aurobindo Pharma Ltd. et al.; Withdrawal of Approval of Eighty-Six Abbreviated New Drug Applications
The Food and Drug Administration (FDA) is withdrawing approval of 86 abbreviated new drug applications (ANDAs) from multiple applicants. The holders of the applications notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
